Search Results - "Borgmann, Anthony J."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    A method for revision of a foreshortened transjugular intrahepatic portosystemic shunt (TIPS) stent using transhepatic trans-stent access by Nguyen, Christian, Robinson, Taylor, Borgmann, Anthony J, Baron, Christopher, Imani, Reza A

    Published in Radiology case reports (01-09-2021)
    “…The high technical success rate of transjugular intrahepatic portosystemic shunt (TIPS) placement makes the procedure a popular treatment option for…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Partition Dosimetry and Outcomes of Metastatic Neuroendocrine Tumors after Yttrium-90 Resin Microsphere Radioembolization by Doyle, Patrick W., Workman, C. Spencer, Grice, Jared V., McGonigle, Trey W., Huang, Shi, Borgmann, Anthony J., Baker, Jennifer C., Taylor, Jason E., Brown, Daniel B.

    “…To characterize estimated mean tumor-absorbed dose (ADT) and objective response of metastatic neuroendocrine tumor (NET) after resin microsphere yttrium-90…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Lobar Radioembolization for Intermediate and Advanced Hepatocellular Carcinoma: Retrospective and Prospective Data by Lakhoo, Janesh, Perez, Thomas H., Borgmann, Anthony J., Brown, Daniel B.

    Published in Seminars in interventional radiology (01-10-2021)
    “…Abstract Historically, outcomes reporting for radioembolization with yttrium-90 (90Y) of hepatocellular carcinoma has included patients across the range of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma by Lang, Daenielle, Agarwal, Rajiv, Brown, Sara A., Borgmann, Anthony J., Lockney, Natalie A., Goff, Laura W., Heumann, Thatcher R.

    Published in Advances in oncology (New York) (01-05-2024)
    “…Patients with unresectable hepatocellular carcinoma (HCC) represent a heterogeneous population - in terms of tumor burden and biology as well as underlying…”
    Get full text
    Journal Article
  12. 12

    Inhibition of NF-κB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays by Estabrook, Neil C., Chin-Sinex, Helen, Borgmann, Anthony J., Dhaemers, Ryan M., Shapiro, Ronald H., Gilley, David, Huda, Nazmul, Crooks, Peter, Sweeney, Christopher, Mendonca, Marc S.

    Published in Free radical biology & medicine (15-12-2011)
    “…We investigated the efficacy and mechanism of dimethylaminoparthenolide (DMAPT), an NF-κB inhibitor, to sensitize human lung cancer cells to X-ray killing in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Inhibition of NF-I super(o)B and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays by Estabrook, Neil C, Chin-Sinex, Helen, Borgmann, Anthony J, Dhaemers, Ryan M, Shapiro, Ronald H, Gilley, David, Huda, Nazmul, Crooks, Peter, Sweeney, Christopher, Mendonca, Marc S

    Published in Free radical biology & medicine (15-12-2011)
    “…We investigated the efficacy and mechanism of dimethylaminoparthenolide (DMAPT), an NF-I super(o)B inhibitor, to sensitize human lung cancer cells to X-ray…”
    Get full text
    Journal Article
  16. 16